首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 製藥 > 癌症 > 歐洲膀胱癌治療市場
產業/市場分類
製藥 (4495)
肥胖症治療 (48)
非專利藥 (117)
疫苗 (168)
神經疾病 (175)
骨頭疾病治療 (41)
動物用醫藥 (18)
處方藥 (89)
規章 (107)
感染疾病 (318)
精神病 (80)
製藥企業 (506)
糖尿病 (157)
癌症 (838)
藥物開發 (1275)
DDS (173)
OTC 非處方藥 (147)
市場調查報告書

歐洲膀胱癌治療市場

European Bladder Cancer Therapeutics Markets

出版商 Frost & Sullivan
出版日期 2007年08月 商品編碼 54338
內容資訊 英文 94 Pages
價格
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


歐洲膀胱癌治療市場 是由出版商Frost & Sullivan在2007年08月所出版的。 這份英文市場調查報告書包含94 Pages 價格從美金6500起跳。

目錄

Abstract

This Frost & Sullivan research service titled European Bladder Cancer Therapeutics Markets presents a concise analysis of the market that includes challenges, factors driving growth and the revenue forecasts from 2003 to 2013. The study identifies the competitive opportunities within the market as well as strategies to exploit these opportunities and overcome industry challenges. In this research, Frost & Sullivan' s expert analysts thoroughly examine the cytotoxic (chemotherapy therapies) and targeted therapies segments.

This analysis is available through our Pharmaceuticals & Biotechnology Growth Partnership Services programme. With this programme, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Table of Contents

1 EXECUTIVE SUMMARY

  • Overview
    • Overview of the Bladder Cancer Therapeutics Market

2 GLOSSARY OF TERMS

  • List of Terms
    • Abbreviations

3 MARKET OVERVIEW

  • Introduction
    • Disease Characteristics
    • Epidemiology
  • Market Definitions and Segmentation
    • Definitions
    • Segmentation

4 RESEARCH METHODOLOGY AT FROST & SULLIVAN

  • Research Objectives and Scope
    • Research Methodology

5 INDUSTRY CHALLENGES

  • Challenges for the Bladder Cancer Market
    • Challenges Faced by Pharmaceutical Companies

6 TOTAL EUROPEAN MARKET FOR BLADDER CANCER THERAPEUTICS

  • Overview and Defintions
    • Introduction
    • Market Drivers
    • Market Restraints
    • Current Therapeutic Options - Superficial Bladder Cancer
    • Current Therapeutic Options - Invasive Bladder Cancer
    • Future Therapeutic Approaches
    • Current Treatment Guidelines
    • Market Engineering Measurement Analysis
  • Competitive Analysis
    • Profiles of Key Industry Participants
    • Market Share Analysis
    • Pipeline Analysis

7 TOTAL FORECASTS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET

  • Forecasts
    • Patient Forecasts and Geographical Trends
    • Market Revenue Forecasts

8 PRICING AND REIMBURSEMENT IN EUROPE

  • Pricing and Reimbursement Issues
    • Pricing and Reimbursement - Country Analysis
    • Pricing and Reimbursement

9 STRATEGIC RECOMMENDATIONS FOR THE EUROPEAN BLADDER CANCER THERAPEUTICS MARKET

  • Market Engineering Recommendations
    • Strategic Recommendations

10 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants
    • Key Participants in the Bladder Cancer Therapeutics Market

11 DECISION SUPPORT DATABASES

  • Habitual Indicators
    • Prevalence of Male Smokers
    • Prevalence of Female Smokers
    • Prevalence of Smokers
  • Healthcare Expenditure
    • Expenditure
    • Per Capita Healthcare Expenditure
  • Cancer Incidence
    • Bladder Cancer Incidence in Western Europe
    • Bladder Cancer Incidence in Selected European Countries
  • Cancer Mortality
    • Bladder Cancer Mortality in Western Europe
    • Bladder Cancer Mortality in Selected European Countries
Back to Top